Gene Control in Infection and Lysogeny by Phage Lambda
Gene Control in Infection and Lysogeny by Phage Lambda
批准号:
8225361
负责人:
JEFFREY W ROBERTS
金额:
$57.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-02-01 至 2014-01-31
关键词:
ATP HydrolysisAffectBacteriaBacteriophage lambdaBacteriophagesBehaviorBiochemical GeneticsBiological AssayBiological ModelsComplementComplexCoupledDNADNA RepairDNA StructureDNA repair proteinDNA-Directed RNA PolymeraseDiseaseElementsElongation FactorGenesGeneticGenetic TranscriptionGenomeHIVHIV InfectionsHealthInfectionLearningLysogenyMediatingModificationMolecularMolecular ConformationMutationNamesNaturePathogenesisPathway interactionsPhaseProcessProteinsRNARNA chemical synthesisRecruitment ActivityRegulationRegulatory PathwayRoleSiteStructureSystemTranscriptTranscription ElongationTranscription ProcessTranscriptional RegulationWorkantiterminationbasedesigngenetic analysisin vivoinsightpreventtranscription termination
中文摘要
描述(申请人提供):这个项目的目标是了解RNA聚合酶对RNA合成的延伸阶段的控制,RNA聚合酶是转录调控的一个关键方面。我们将利用一种特定的抗终止子蛋白,即噬菌体lambda的Q蛋白,它成为基因组特定位置的RNA聚合酶的一个亚单位,从而通过阻止转录终止来允许下游基因的表达。该蛋白提供了一个高度明确和可访问的系统,用于从机制上深入了解控制转录延长的通用酶过程;例如,HIV病毒的Tat蛋白是转录延长的调节因子,其作用方式与lambda Q蛋白和其他细菌抗终止物有许多相似之处。对这些机制的详细了解将使治疗方法依赖于特定分子制剂的设计。我们将学习一种结构修饰的本质,称为lambda Q蛋白在RNA聚合酶中诱导的屏障,以使其对终止子不敏感。我们将通过生化和遗传分析,研究转录延伸因子NusA在构建屏障中的作用。我们将利用突变分析来发现lambda Q蛋白修饰RNA聚合酶的位置和途径,特别是了解Q是如何调节转录暂停的,这是RNA聚合酶的一种普遍功能行为。这项工作将补充我们理解终止机制本身的持续努力。我们还将研究MFD蛋白的作用机制,它介导转录偶联DNA修复过程,并在招募DNA修复蛋白时解离停滞的伸长复合体。了解MFD如何利用ATP的能量将有助于阐明MFD的终止机制以及终止过程中涉及的能量势垒。利用细菌和噬菌体模型系统,该项目有助于理解基因调控的基本机制,这项工作对于发现疾病的分子基础至关重要。它还直接调查与艾滋病毒致病和有毒细菌感染相关的调控途径。
英文摘要
DESCRIPTION (provided by applicant): The objective of this project is to understand control of the elongation phase of RNA synthesis by RNA polymerase, a critical facet of transcription regulation. We will utilize a specific antiterminator protein, the Q protein of bacteriophage lambda, which becomes a subunit of RNA polymerase at a genome-specific site and thereby allows expression of downstream genes by preventing transcription termination. This protein provides a highly defined and accessible system with which to obtain mechanistic insights into universal enzymatic processes that control transcription elongation; for example, the TAT protein of the HIV virus is a regulator of transcription elongation that acts in many ways like lambda Q protein and other bacterial antiterminators. A detailed understanding of these mechanisms will allow approaches to therapies that depend upon the design of specific molecular agents. We will learn the nature of a structural modification, named a barrier that lambda Q protein induces in RNA polymerase in order to make it insensitive to terminators. We will study the role of the transcription elongation factor NusA in constructing the barrier, through biochemical and genetic analysis. We will use mutational analysis to discover the sites and pathways of modification of RNA polymerase by lambda Q protein, in particular to understand how Q regulates transcription pausing, a universal functional behavior of RNA polymerase. This work will complement our continuing efforts to understand the mechanism of termination itself. We also will study the mechanism of action of the protein Mfd, which mediates the process of transcription-coupled DNA repair, and acts to dissociate stalled elongation complexes as it recruits DNA repair proteins. Understanding how the energy of ATP is used by Mfd will illuminate the mechanism of termination and the energetic barriers involved in termination. PUBLIC HEALTH RELEVANCE Using bacterial and bacteriophage model systems, this project contributes to understanding basic mechanisms of genetic regulation, an undertaking essential to discovering the molecular basis of disease. It also directly investigates regulatory pathways related to those essential to pathogenesis by HIV and infection by toxic bacteria.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The phage lambda gene Q transcription antiterminator binds DNA in the late gene promoter as it modifies RNA polymerase.
噬菌体 lambda 基因 Q 转录抗终止子在修饰 RNA 聚合酶时与晚期基因启动子中的 DNA 结合。
DOI:
10.1016/0092-8674(92)90639-t
发表时间:
1992
期刊:
Cell
影响因子:
64.5
作者:
[Yarnell,WS, Roberts,JW]
通讯作者:
Roberts,JW
Specificity and mechanism of antitermination by Q proteins of bacteriophages lambda and 82.
噬菌体 lambda 和 82 的 Q 蛋白抗终止的特异性和机制。
DOI:
10.1016/0022-2836(89)90122-8
发表时间:
1989
期刊:
Journal of molecular biology
影响因子:
5.6
作者:
[Yang,XJ, Goliger,JA, Roberts,JW]
通讯作者:
Roberts,JW
RecA protein--promoted lambda repressor cleavage: complementation between RecA441 and RecA430 proteins in vitro.
RecA 蛋白——促进 lambda 阻遏蛋白裂解:体外 RecA441 和 RecA430 蛋白之间的互补。
DOI:
10.1007/bf00328696
发表时间:
1984
期刊:
Molecular & general genetics : MGG
影响因子:
--
作者:
[Moreau,PL, Roberts,JW]
通讯作者:
Roberts,JW
A potential stem-loop structure and the sequence CAAUCAA in the transcript are insufficient to signal rho-dependent transcription termination at lambda tR1.
转录本中潜在的茎环结构和序列 CAAUCAA 不足以发出 lambda tR1 处 rho 依赖性转录终止的信号。
DOI:
10.1093/nar/12.2.1287
发表时间:
1984
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Lau,LF, Roberts,JW, Wu,R, Georges,F, Narang,SA]
通讯作者:
Narang,SA
Two transcription pause elements underlie a σ70-dependent pause cycle.
两个转录暂停元件构成了依赖于 70 的暂停周期。
DOI:
10.1073/pnas.1512986112
发表时间:
2015
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Strobel,EricJ, Roberts,JeffreyW]
通讯作者:
Roberts,JeffreyW
共 22 条
CRYSTAL STRUCTURE OF ECOLI RNA POLYMERASE-NUSA AND MECHANISM OF
-
批准号:8363540
-
项目类别:
-
资助金额:$2.38万
-
财政年份:2011
-
负责人:JEFFREY W ROBERTS
-
依托单位:
CRYSTAL STRUCTURE OF ECOLI RNA POLYMERASE-NUSA AND MECHANISM OF
-
批准号:8171532
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2010
-
负责人:JEFFREY W ROBERTS
-
依托单位:
FASEB CONFERENCE--PROKARYOTIC TRANSCRIPTION INITIATION
-
批准号:2883853
-
项目类别:
-
资助金额:$0.5万
-
财政年份:1999
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:2331947
-
项目类别:
-
资助金额:$37.92万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:2765453
-
项目类别:
-
资助金额:$55.77万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:7010707
-
项目类别:
-
资助金额:$63.36万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:7171498
-
项目类别:
-
资助金额:$63.13万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
Gene Control in Infection and Lysogeny by Phage Lambda
-
批准号:8063645
-
项目类别:
-
资助金额:$58.4万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:2173838
-
项目类别:
-
资助金额:$35.53万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:6498566
-
项目类别:
-
资助金额:$56.79万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
Gene Control in Infection and Lysogeny by Phage Lambda
-
批准号:7581182
-
项目类别:
-
资助金额:$61.81万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:2654931
-
项目类别:
-
资助金额:$39.41万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:7342027
-
项目类别:
-
资助金额:$62.91万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:3270807
-
项目类别:
-
资助金额:$23.83万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:3270806
-
项目类别:
-
资助金额:$19.71万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:3270812
-
项目类别:
-
资助金额:$22.4万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION & LYSOGENY BY PHAGE LAMBDA
-
批准号:3270814
-
项目类别:
-
资助金额:$25.94万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:6351166
-
项目类别:
-
资助金额:$55.15万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
Gene Control in Infection and Lysogeny by Phage Lambda
-
批准号:7764676
-
项目类别:
-
资助金额:$62.07万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
GENE CONTROL IN INFECTION AND LYSOGENY BY PHAGE LAMBDA
-
批准号:3270810
-
项目类别:
-
资助金额:$22.01万
-
财政年份:1978
-
负责人:JEFFREY W ROBERTS
-
依托单位:
海外基金